Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis

被引:0
|
作者
Debang Li
Bin Hu
Yanming Zhou
Tao Wan
Xiaoying Si
机构
[1] First Hospital of Lanzhou University,Department III of General Surgery
[2] First affiliated Hospital of Xiamen University,Department of Clinical Laboratory Medicine
[3] First affiliated Hospital of Xiamen University,Department of Hepatobiliary & Pancreatovascular Surgery
来源
BMC Cancer | / 18卷
关键词
Pancreatic ductal adenocarcinoma; Resection; Size; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [11] Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis
    Parmar, Ambica
    Chaves-Porras, Jorge
    Saluja, Ronak
    Perry, Kaitlyn
    Rahmadian, Amanda P.
    Delos Santos, Seanthel
    Ko, Yoo-Joung
    Berry, Scott
    Doherty, Mark
    Chan, Kelvin K. W.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 145
  • [12] Higher notch expression implies poor survival in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
    Ye, Jianbin
    Wen, Junjie
    Ning, Yunshan
    Li, Yan
    [J]. PANCREATOLOGY, 2018, 18 (08) : 954 - 961
  • [13] Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
    Jee-Soo Lee
    Tae-Min Rhee
    Daniel Pietrasz
    Jean-Baptiste Bachet
    Pierre Laurent-Puig
    Sun-Young Kong
    Erina Takai
    Shinichi Yachida
    Tatsuhiro Shibata
    Jung Woo Lee
    Hyoung-chul Park
    Dae Young Zang
    Kibum Jeon
    Jiwon Lee
    Miyoung Kim
    Han-Sung Kim
    Hee Jung Kang
    Young Kyung Lee
    [J]. Scientific Reports, 9
  • [14] Immune Response With Tumor-infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma: a Systematic Review and Meta-analysis
    Miksch, R. C.
    Weniger, M.
    D'Haese, J. G.
    Bazhin, A. V.
    Werner, J.
    [J]. PANCREAS, 2019, 48 (10) : 1491 - 1491
  • [15] Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
    Lee, Jee-Soo
    Rhee, Tae-Min
    Pietrasz, Daniel
    Bachet, Jean-Baptiste
    Laurent-Puig, Pierre
    Kong, Sun-Young
    Takai, Erina
    Yachida, Shinichi
    Shibata, Tatsuhiro
    Lee, Jung Woo
    Park, Hyoung-chul
    Zang, Dae Young
    Jeon, Kibum
    Lee, Jiwon
    Kim, Miyoung
    Kim, Han-Sung
    Kang, Hee Jung
    Lee, Young Kyung
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [16] Systematic Review and Meta-Analysis of Immunohistochemical Diagnostic Markers for Pancreatic Ductal Adenocarcinoma
    Ali, D.
    [J]. JOURNAL OF PATHOLOGY, 2013, 231 : 17 - 17
  • [17] Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis
    Jamieson, Nigel B.
    Carter, C. Ross
    McKay, Colin J.
    Oien, Karin A.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (10) : 3316 - 3331
  • [18] A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma
    Lewis, Russell
    Drebin, Jeffrey A.
    Callery, Mark P.
    Fraker, Douglas
    Kent, Tara S.
    Gates, Jenna
    Vollmer, Charles M., Jr.
    [J]. HPB, 2013, 15 (01) : 49 - 60
  • [19] Impact of Acute Inflammation on the Survival Outcomes of Patients with Resected Pancreatic Ductal Adenocarcinoma
    Saad, Mohamed Rabie
    Han, Ho-Seong
    Yoon, Yoo-Seok
    Cho, Jai Young
    Lee, Jun Suh
    Shehta, Ahmed
    [J]. DIGESTIVE SURGERY, 2021, 38 (5-6) : 343 - 351
  • [20] Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis
    Tamburrino, Domenico
    Crippa, Stefano
    Partelli, Stefano
    Archibugi, Livia
    Arcidiacono, Paolo Giorgio
    Falconi, Massimo
    Capurso, Gabriele
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 (04) : 392 - 399